Torrent Pharma Inc. is recalling 634,092 bottles of various blood pressure medications, including Valsartan and Amlodipine combination tablets, because a carcinogen impurity was detected in the active ingredient. The recall includes multiple strengths and combinations of these prescription drugs used to treat hypertension. Consumers using these medications should continue taking them until they have spoken with a healthcare professional, as the risk of stopping the medication suddenly may be greater than the risk of the impurity.
The medications contain an impurity in the active pharmaceutical ingredient that is classified as a potential human carcinogen. Long-term exposure to this substance could potentially increase the risk of developing cancer.
Pharmaceutical product return for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.